 Obalon Therapeutics, Inc. NASDAQ:OBLN, a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that William Plovanic, the Companys President and CEO has announced his resignation in order to accept another position. To assist the Company in the transition, Mr. Plovanic has agreed to remain as President and CEO through completion and filing of Obalons Form 10-Q for the quarter ended March 31, 2020 the Quarterly Report. 